Other
Personalised medicine: Priority setting and opportunity costs in European public health care systems
Jochen Vollmann
; Institut für Medizinische Ethik und Geschichte der Medizin, Ruhr-Universität Bochum, Germany
Abstract
“Personalised medicine” is currently attracting considerable attention and raising high hopes and expectations in modern medicine. The term “personalised medicine” denotes the use of genetic or other biomarker information, and it does not focus on a more personal
patient-doctor relationship. Furthermore, personalised medicine is associated with ethical problems like priority setting and opportunity costs in solidarity-based public health care systems. Personalised medicine provides modern, highly specific and expensive diagnostics
and treatments, which serve only limited subgroups of patients. At the same time, research in other fields of clinical medicine, which could be of benefit to more patients than such limited subgroups, remain underfunded.
Keywords
Personalised medicine; Person; Priority setting; Opportunity costs; Health economics
Hrčak ID:
153733
URI
Publication date:
1.12.2015.
Visits: 1.082 *